Tafuri Silvio, Prato Rosa, Martinelli Domenico, Calvario Agata, Bozzi Anna, Labianca Michele, Patti Annamaria, Lopalco Pietro Luigi, Germinario Cinzia
Department of Biomedical Sciences, Section of Hygiene, University of Bari, Apulia Regional Epidemiological Observatory, Bari, Italy.
BMC Infect Dis. 2008 Oct 30;8:150. doi: 10.1186/1471-2334-8-150.
In 1988 the World Health Assembly adopted the goal to eradicate poliomyelitis by routine immunization using Oral Polio Vaccine (OPV). On 21 June 2002 the WHO European Region was declared polio-free. In 2008 poliomyelitis is still endemic in 4 countries (Nigeria, India, Pakistan, and Afghanistan), where 1201 new cases were registered in 2007; 107 sporadic cases were also notified in countries where poliovirus is not endemic. The aim of this work was to verify the level of antipoliomyelitis immunity status in children and adolescents in the Apulia region (south of Italy), which may be considered a border region due to its position.
704 blood specimens from a convenience sample were collected in six laboratories. The age of subjects enrolled was 0-15 years. The immunity against poliomyelitis was evaluated by neutralizing antibody titration in tissue culture microplates.
Seropositivity (neutralising antibodies titre > or = 8) for polioviruses 1, 2 and 3 was detected in 100%, 99.8% and 99.4% of collected sera. Antibody titres were not lower in subjects who received either four doses of inactivated polio vaccine (IPV) or a sequential schedule consisting of two doses of IPV and two of oral polio vaccine than in subjects who received four doses of OPV.
These results confirmed current data of vaccine coverage for poliomyelitis: during the last ten years in Apulia, the coverage in 24 months old children was more than 90%. The high level of immunization found confirms the effectiveness both of the sequential schedule IPV-OPV and of the schedule all-IPV. Apulia region has to face daily arrivals of refugees and remains subject to the risk of the importation of poliovirus from endemic areas. Surveys aimed at determining anti-polio immunity in subpopulations as well as in the general population should be carried out.
1988年,世界卫生大会通过了目标,即通过使用口服脊髓灰质炎疫苗(OPV)进行常规免疫来根除脊髓灰质炎。2002年6月21日,世卫组织欧洲区域被宣布无脊髓灰质炎。2008年,脊髓灰质炎在4个国家(尼日利亚、印度、巴基斯坦和阿富汗)仍然流行,2007年在这些国家登记了1201例新病例;在脊髓灰质炎病毒非流行国家也报告了107例散发病例。这项工作的目的是核实普利亚地区(意大利南部)儿童和青少年的抗脊髓灰质炎免疫状况水平,由于其地理位置,该地区可被视为边境地区。
在六个实验室收集了来自便利样本的704份血液标本。纳入研究的受试者年龄为0至15岁。通过在组织培养微孔板中进行中和抗体滴定来评估对脊髓灰质炎的免疫力。
在收集的血清中,1型、2型和3型脊髓灰质炎病毒的血清阳性率(中和抗体滴度≥8)分别为100%、99.8%和99.4%。接受四剂灭活脊髓灰质炎疫苗(IPV)或由两剂IPV和两剂口服脊髓灰质炎疫苗组成的序贯接种程序的受试者的抗体滴度并不低于接受四剂OPV的受试者。
这些结果证实了目前脊髓灰质炎疫苗接种覆盖率的数据:在过去十年中,普利亚地区24个月大儿童的接种覆盖率超过90%。发现的高免疫水平证实了IPV-OPV序贯接种程序和全IPV接种程序的有效性。普利亚地区每天都要面对难民的到来,仍然面临着从流行地区输入脊髓灰质炎病毒的风险。应开展旨在确定亚人群以及一般人群中抗脊髓灰质炎免疫力的调查。